Advertisements


Can-Fite BioPharma announces final data from Namodenoson study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Seelos Therapeutics announces final data from Phase 1 PK/PD study of SLS-002

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2020

Can-Fite BioPharma says new data shows Namodenoson induces weight loss

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 3rd, 2020

Can-Fite BioPharma announces results from Namodenoson End-of-Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 31st, 2019

Can-Fite BioPharma completes enrollment in Phase II NASH study of Namodenoson

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2019

PolarityTE announces final clinical data from SkinTE pilot study in DFUs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 10th, 2019

Wave Life Sciences Plunges After DMD Study Data Readout

Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage developm.....»»

Category: dealsSource: nytApr 17th, 2019

Can-Fite BioPharma to present data from Phase 2 NAFDL/NASH study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

Roche Announces Positive Data on Gazyva and MS Drug Ocrevus

Roche (RHHBY) announced positive long-term data on leukemia drug Gazyva and MS drug Ocrevus. Roche RHHBY announced encouraging data from the final analysis of the CLL11 study, evaluating Gazyva-based treatment in previously untreated.....»»

Category: smallbizSource: nytJun 15th, 2018

CTI BioPharma announces continuation of PAC203 study after interim data review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

RedHill Biopharma announces final patient assessed in Talicia study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Achieve Life Sciences announces final data from cytisinicline study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 22nd, 2019

RedHill Biopharma announces publication of data from COVID-19 patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2020

Provectus announces data from ongoing preclinical study of PV-10

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 22nd, 2020

Teva announces new Ajovy data from FOCUS study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2020

Provention Bio announces extended follow-up data from "At-Risk" TN-10 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2020

Principia Biopharma announces data from BELIEVE-PV trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2020

Bluebird Bio announces new data from Group C of HGB-206 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2020

Bluebird Bio announces new data from betibeglogene autotemcel study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2020

Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020

Completed enrollment of cohort 2 of SUNRISE-PD Phase 2 study of AXO-Lenti-PD in Parkinson's disease, with data from this cohort expected in Q4 2020 Completed enrollment of low-dose cohort of Phase 1/2 clinical study of AXO-A.....»»

Category: smallbizSource: nytJun 10th, 2020

Can-Fite BioPharma concludes meeting with EMA on Phase 3 Namodenoson development

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2020